Skip to main content

Table 1 Characteristics of the trials included in the analysis

From: Perioperative statin therapy in cardiac and non-cardiac surgery: a systematic review and meta-analysis of randomized controlled trials

Trial

Journal

Surgical procedure

Number of patients

Statin

Statin regimen

Control

Patients naïve to statin therapy (%)

Outcomes for meta-analysis

Risk of bias

Cardiac surgery

Almansob 2012

Arterioscler Thromb Vasc Biol

Non-coronary cardiac surgery

132

Simvastatin 20 mg

5–7 days pre-op and post-op day 2

No treatment

nr

MI, S, M

High

Aydin 2015

Anatol J Cardiol

On-pump CABG

60

Atorvastatin

7 h post-op and 30 days post-op

No treatment

100

MI, M

High

Baran 2011

Stem Cell Rev and Rep

On-pump CABG

60

Atorvastatin 40 mg

14 days pre-op and post-op (no day 0)

Placebo

100

AKI, MI, S, M, RRT

High

Berkan 2008

Thorac Cardiov Surg

On-pump CABG

46

Fluvastatin 80 mg

3 weeks pre-op

Placebo

100

MI

High

Billings 2016

JAMA

On-/Off-pump cardiac surgery

615

Atorvastatin 40 mg

Bid day 1, qd day 0, and qd post-op°

Placebo

32

AKI, MI, S, M, RRT

Low

Carrascal 2016

Journal of Arrhythmia

Valvular surgery

90

Atorvastatin 40 mg

7 days pre-op and 7 days post-op

No treatment

100

AKI, MI, S, M, RRT

High

Castaño 2015

J Cardiovasc Surg

On-pump CABG

30

Pravastatin 40 or 80 mg

2 h pre-op

Placebo

0

AKI, MI, S, M, RRT

Low

Chello 2006

Crit Care Med

On-pump CABG

40

Atorvastatin 20 mg

3 weeks pre-op

Placebo

100

AKI, MI, S, M

Unclear

Christenson 1998

Eur J Cardiothorac Surg

On-pump CABG

77

Simvastatin 20 mg

4 weeks pre-op

No treatment

nr

AKI, MI, M

High

Dehghani 2014

J Cardiovasc Pharmacol Ther

Valvular surgery

58

Atorvastatin 40 mg

3 days pre-op and 5 days post-op

Placebo

100

MI, S, M

High

Hua 2017

Biomed Res Int

Valvular surgery

130

Simvastatin 20 mg

5–7 days pre-op and 7 days post-op (no days 0–1).

Placebo

100

M

High

Ji 2009

Circ J

Off-pump CABG

140

Atorvastatin 20 mg

7 days pre-op

Placebo

100

MI, S, M

High

Mannacio 2008

J Thorac Cardiovasc Surg

On-pump CABG

200

Rosuvastatin 20 mg

7 days pre-op

Placebo

100

AKI, MI, S, M

High

Mansour 2016

Int J Adv Biomed

Cardiac surgery

50

Atorvastatin 40 mg

7 days pre-op and post-op

No treatment

100

MI, S, M

High

Nakamura 2006

Cytokine

On-/Off-pump CABG

31

Atorvastatin 10 mg

Unclear

No treatment

32

M

Unclear

Park 2016

Intensive Care Med

Valvular surgery

200

Atorvastatin 40 mg

Bid day − 1 and qd days 0–1–2

Placebo

100

AKI, MI, S, M, RRT

Low

Patti 2006

Circulation

On-pump cardiac surgery

200

Atorvastatin 40 mg

7 days pre-op and post-op until discharge (no day 0)

Placebo

100

MI, M

High

Prowle 2012

Nephrology

On-pump cardiac surgery

100

Atorvastatin 40 mg

Days 0–1–2–3

Placebo

30

AKI, M, RRT

Low

Song 2008

Am Heart J

Off-pump CABG

124

Atorvastatin 20 mg

3 days pre-op and continued for 30 days post-op

No treatment

100

MI, S

High

Spadaccio 2010

J Cardiovasc Pharmacol

On-pump CABG

50

Atorvastatin 20 mg

3 weeks pre-op

Placebo

100

AKI, MI, S, M

Unclear

Sun 2011

Int Heart J

On-pump CABG

100

Atorvastatin 20 mg

7 days pre-op

Placebo

100

MI

High

Tamayo 2009

J Thorac Cardiovasc Surg

On-pump CABG

44

Simvastatin 20 mg

3 weeks pre-op

No treatment

100

M

High

Vukovic 2010

Perfusion

On-pump CABG

57

Atorvastatin 20 mg

3 weeks pre-op

Placebo

100

MI, M

High

Youn 2011

Korean J Thorac Cardiovasc Surg

Off-pump CABG

142

Rosuvastatin 40 mg

Bid day 1, qd day 0

No treatment

45

MI, M

High

Zheng 2016

N Engl J Med

On–/Off-pump CABG/AVR/CABG + AVR

1922

Rosuvastatin 20 mg

1–8 days pre-op and 5 days post-op

Placebo

66

AKI, MI, S, M, RRT

Low

Non-cardiac surgery

Amar 2015

J Thorac Cardiovasc Surg

Pulmonary resection

88

Atorvastatin 40 mg

7 days pre-op and 7 days post-op

Placebo

100

MI, M

High

Bass 2018

HSSJ

Hip fracture and total hip/knee replacement surgery

20

Atorvastatin 40 mg

4 days pre-op and 45 days post-op

Placebo

100

AKI, MI, S, M

High

Berwanger 2017

Am Heart J

Non-cardiac surgery in high-risk patientsa

642

Atorvastatin 80 mg

1 day pre-op and seven days post-op

Placebo

100

AKI, MI, S, M

High

Durazzo 2004

J Vasc Surg

Aortic, femoropopliteal, and carotid vascular surgery

100

Atorvastatin 20 mg

At least 14 days pre-op and up to 4 weeks post-op

Placebo

100

MI, S, M

Low

Neilipovitz 2012

Can J Anaesth

Non-cardiac surgery in high-risk patientsb

76

Atorvastatin 80 mg

7 days pre-op and 7 days post-op or day 0 and 7 days post-op

Placebo

100

MI, S, M

High

Parepa 2017

Farmacia

Elective non-cardiac, non- vascular surgery without known cardiac disease

1380

Rosuvastatin 10 mg

10 days pre-op and 20 days post-op

Placebo

100

MI, M

High

Shyamsundar 2014

Annals of Surgery

Esophagectomy

31

Simvastatin 80 mg

4 days pre-op and 7 days post-op

Placebo

100

AKI, MI, S, M

Unclear

Singh 2016

J Am Coll Surg

Colorectal resection or reversal of Hartmann’s procedure surgery

132

Simvastatin 40 mg

3–7 days pre-op and 14 days post-op

Placebo

100

M

Low

Xia 2014

Cardiology

Urgent abdominal surgeryc in patients with stable CAD

500

Atorvastatin 80 mg

2 h before surgery

Placebo

0

MI, M

Low

Xia 2015

Cardiology

Urgent abdominal surgeryc in patients with stable CAD

550

Rosuvastatin 20 mg

2 h before surgery

Placebo

0

MI, S, M

Unclear

  1. AKI, acute kidney injury; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; CAD, coronary artery disease; M, mortality; MI, myocardial infarction; RRT, renal replacement therapy; nr, not reported; pre-op, pre-operatively; post-op, post-operatively; day 0, the morning of the day of surgery; qd, once a day; bid, twice a day; °, patients on chronic statin therapy received study drug only on day 0 and day 1, resuming chronic statin therapy on postoperative day 2
  2. aDefined as: history of CAD, peripheral vascular disease, stroke, major vascular surgery, or any 3 of 7 risk factors criteria (intrathoracic or intraperitoneal surgery, congestive heart failure, transient ischemic attack, diabetes, renal failure, age > 70 years, or emergent/urgent surgery)
  3. bDefined as: history of CAD, peripheral vascular disease, stroke, or congestive heart failure, or three of six risk factor (high-risk surgery, previous congestive heart failure, diabetes, renal failure, age > 70 years, previous transient ischemic attack)
  4. cAcute suppurative appendicitis, acute cholecystitis, acute cholangitis, acute pancreatitis, peptic ulcer perforation or urinary calculi